C7 ester substituted taxanes

Details C7 ester substituted taxanes C7 ester substituted taxanes

2007-03-06

2007-03-06

Seaman, D. Margaret (Department: 1625)

Organic compounds -- part of the class 532-570 series

Organic compounds

Heterocyclic carbon compounds containing a hetero ring...

C549S471000, C549S473000, C549S510000, C549S511000, C514S449000

Reexamination Certificate

active

10606027

ABSTRACT:
Taxanes having an ester substituent at C(7), a hydroxy substituent at C(10), and a range of C(2), C(9), C(14), and side chain substituents.

REFERENCES:
patent: 4960790 (1990-10-01), Stella et al.
patent: 5175315 (1992-12-01), Holton
patent: 5200534 (1993-04-01), Rao
patent: 5227400 (1993-07-01), Holton et al.
patent: 5243045 (1993-09-01), Holton et al.
patent: 5248796 (1993-09-01), Chen et al.
patent: 5283253 (1994-02-01), Holton et al.
patent: 5319112 (1994-06-01), Kingston et al.
patent: 5350866 (1994-09-01), Holton et al.
patent: 5352806 (1994-10-01), Gunawardana et al.
patent: 5415869 (1995-05-01), Straubinger et al.
patent: 5422364 (1995-06-01), Nicolaou et al.
patent: 5430160 (1995-07-01), Holton
patent: 5489601 (1996-02-01), Holton et al.
patent: 5530020 (1996-06-01), Gunawardana et al.
patent: 5567614 (1996-10-01), Patel et al.
patent: 5614645 (1997-03-01), Kingston et al.
patent: 5714513 (1998-02-01), Holton et al.
patent: 5721268 (1998-02-01), Holton et al.
patent: 5767297 (1998-06-01), Mandai et al.
patent: 5780653 (1998-07-01), Tao et al.
patent: 5811452 (1998-09-01), Ojima et al.
patent: 5879929 (1999-03-01), Patel
patent: 5912264 (1999-06-01), Wittman et al.
patent: 5965739 (1999-10-01), Kelly et al.
patent: 6136988 (2000-10-01), Murray et al.
patent: 6610860 (2003-08-01), Holton
patent: 2001/0002404 (2001-05-01), Webb et al.
patent: 0 558 959 (1993-09-01), None
patent: 0 590 267 (1994-04-01), None
patent: 0 629 701 (1994-12-01), None
patent: 0 747 385 (2002-08-01), None
patent: WO 90/10443 (1990-09-01), None
patent: WO 93/02065 (1993-02-01), None
patent: WO 94/14787 (1994-07-01), None
patent: WO 95/11241 (1995-04-01), None
patent: WO 95/13053 (1995-05-01), None
patent: WO 97/09979 (1997-03-01), None
patent: WO 97/42181 (1997-11-01), None
patent: WO 97/44026 (1997-11-01), None
patent: WO 97/44063 (1997-11-01), None
patent: WO 99/09021 (1999-02-01), None
patent: WO 00/01366 (2000-01-01), None
patent: WO 00/78707 (2000-12-01), None
patent: WO 01/25223 (2001-04-01), None
patent: WO 01/57013 (2001-08-01), None
patent: WO 01/57027 (2001-08-01), None
patent: WO 01/68089 (2001-09-01), None
Deutsch et al. “Synthesis of Congeners and Prodrugs. 3. Water-Soluble Prodrugs of Taxol with Potent Antitumor Activity” Journal of Medicinal Chemistry, vol. 32, No. 4 (1989) pp. 788-792.
Dubois et al. “Fluorescent and Biotinylated Analogues of Docetaxel: Synthesis and Biological Evaluation” Bioorganic & Medicinal Chemistry, vol. 3, No. 10 (1995) pp. 1357-1368.
European Search Report for EP 01 10 2160 dated Jul. 9, 2001.
Ferlini et al. “Antitumor Activity of Novel Taxanes that Act at the Same Time as Cytotoxi Agents and P-Glycoprotein Inhibitors” British Journal of Cancer, vol. 83, No. 12 (2000) pp. 1762-1768.
Guenard et al. “Effects of the Hydrophobicity of Taxoids on their Interaction with Tubulin” Bioorganic & Medicinal Chemistry, vol. 8 (2000) pp. 145-156.
Gueritte-Voegelein et al. “Relationships between the Structure of Taxol Analogues and Their Antimitotic Activity” Journal of Medicinal Chemistry, vol. 34, No. 3 (1991) pp. 992-998.
International Search report for analogous PCT Application No. PCT/US01/03385 dated Jun. 11, 2001.
Ishihara et al. “Scandium Trifluoromethanesulfonate as an Extremely Active Acylation Catalyst” J. Am. Chem. Soc., vol. 117, No. 15 (1995) pp. 4413-4414.
Kingston et al. “The Chemistry of Taxol, A Clinically Useful Anticancer Agent” Journal of Natural Products, vol. 53, No. 1 (1990) pp. 1-12.
Klein “Synthesis of 9-Dihydrotaxol: A Novel Bioactive Taxane” Tetrahedron Letters, vol. 34, No. 13 (1993) pp. 2047-2050.
Liang et al. “Synthesis and Biological Evaluation of Paclitaxel Analogs Modified in Ring C” Tetrahedron Letters, vol. 36, No. 17 (1995) pp. 2901-2904.
Mellado et al. “Preparation and Biological Activity of Taxol Acetates” Biochemical and Biophysical Research Communications, vol. 124, No. 2 (1984) pp. 329-336.
Ojima et al. “New Photoaffinity Analogs of Paclitaxel” Bioorganic & Medicinal Chemistry Letters, vol. 9 (1999) pp. 1189-1194.
Patel “Tour De Paclitaxel: Biocatalysis for Semisynthesis” Annu. Rev. Microbiol. vol. 52 (1998) pp. 361-395.
Shi et al. “Studies on the Quantitative Structure-Activity Relationships of Paclitaxel Analogues” Gaodeng, Xuexiao, Huaxue Xuebao, vol. 21, No. 3 (2000) pp. 401-406.
Straubinger et al. “Pharmacology and Antitumor Effect of Novel Placlitaxel Formulations” Chapter 8, Edited by G. Georg et al., Taxane Anticancer Agents, Basic Science and Current Status, ACS Symposium Series 583, 207th National Meeting of the American Chemical Society, San Diego, CA (1994) pp. 111-123.
Suffness “Chapter 32. Taxol: From Discovery to Therapeutic Use” Annual Reports in Medicinal Chemistry, vol. 28 (1993) pp. 305-314.
Vyas et al. “Phosphatase-Activated Prodrugs of Paclitaxel” Chapter 9, Edited by G. Georg et al., Taxane Anticancer Agents, Basic Science and Current Status, ACS Symposium Series 583, 207th National Meeting of the American Chemical Society, San Diego, CA (1994) pp. 124-137.
Journal of Tianjin University, (2000), pp. 51-55, vol. 33:1.
Hungarian Search Report from P0103247 dated Dec. 14, 2004.

Affiliated with

Also associated with

Rating

C7 ester substituted taxanes does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with C7 ester substituted taxanes, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and C7 ester substituted taxanes will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3747916